The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Janumet

50/850 milligram(s) Film-coated tablet

Merck Sharp and Dohme LimitedEU/1/08/455/1-7

Main Information

Trade NameJanumet
Active SubstancesSitagliptin phosphate
METFORMIN HYDROCHLORIDE
Strength50/850 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMerck Sharp and Dohme Limited
Licence NumberEU/1/08/455/1-7

Group Information

ATC CodeA10BD Combinations of oral blood glucose lowering drugs
A10BD07 metformin and sitagliptin

Status

Authorised/WithdrawnAuthorised
Licence Issued16/07/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back